Back

Usefulness of cardiac magnetic resonance imaging for early detection of subclinical chemotherapy-related cardiac dysfunction in cancer patients

2 September 2019 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Cardio-Oncology: insights from basic , clinical, data science Cardiotoxicity of Drugs and Other Therapies ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Yosuke Terui

Tohoku University, Sendai (Japan)

6 More presentations in this session

Presentation thumbnail
Effect of calcitriol attenuates doxorubicin-induced cardiac dysfunction in mice model: focus on endothelial-to-mesenchymal transition
Doctor T. Tsai (Kaohsiung, TW)
Abstract
Presentation thumbnail
New role of EPAC1 in Anthracycline-induced cardiotoxicity and anticancer therapy
Miss A. BELHADEF (Chatenay-Malabry, FR)
Abstract
Presentation thumbnail
CMR Fast-SENC intramyocardial LV & RV segmental strain detects cardiotoxicity during oncology treatment and impact of cardioprotection therapy before echocardiography
Doctor M. Montenbruck (Hamburg, DE)
Abstract
Presentation thumbnail
Malignancy after Heart Transplantation: Difference in incidence and prognosis between genders. Data from the Spanish post-Heart Transplant Tumor Registry.
Doctor C. Minguito Carazo (A Coruna, ES)
Abstract Slides
Presentation thumbnail
Prevention of heart failure in treatments with trastuzumab and anthracyclines: a meta-analysis
Professor F. Braunschweig (Stockholm, SE)
Abstract Slides

Access the full session

Session thumbnail
Cardio-Oncology: insights from basic , clinical, data science

The Event

Event poster

ESC Congress 2019

2 September 2019 10:05 CET
You may be interested in
thumbnail
Congress Session
Chronic kidney disease and heart failure
thumbnail
Congress Session
Rare causes of heart failure
thumbnail
Congress Session
Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments